2026 expert consensus on antioxidant use in male infertility

A 2026 expert consensus from the Global Andrology Forum reviews how antioxidants are used in male infertility, showing which practices are supported by expert agreement and where evidence is still lacking.

Antioxidants are widely used, but research results have been inconsistent, with studies differing in who was studied, which supplements were used, how long they were taken, and which outcomes were measured. Because of this, major organizations like the EAU and AUA/ASRM have been cautious about recommending them.

The Global Andrology Forum (GAF) developed guidelines on the use of antioxidants for male infertility. They used an expert consensus process, with 151 clinicians voting on proposed guidelines and 84 senior experts rating each as a strong or weak based on the evidence and riskโ€“benefit balance.

High-quality randomized trials and standardized testing methods are still lacking, and these guidelines could change as stronger evidence emerges.

โš ๏ธ Remembryo summarizes and interprets IVF research for educational purposes. Posts highlight selected findings and may simplify or omit study details, including methods, analyses, author interpretations, limitations, and protocol specifics (such as timing, dosing, or eligibility criteria). These summaries are not a substitute for the original study. Always review the full publication before treatment decisions.

๐Ÿ”— Original studies are referenced in this post or within the linked Remembryo posts.

๐Ÿ’ก Reminder: Terms underlined with a dotted black line are linked to glossary entries. Clicking these does not count toward your paywall limit.

GAFโ€™s strongly recommended guidelines

These guidelines were โ€œstronglyโ€ rated, meaning that at least 80% of experts rated the guideline as strong.

  1. A full male infertility workup should be done before starting antioxidant supplements (100%)
    • Evidence: Strong agreement across international guidelines and expert panels that supplements should not replace proper testing for hormonal, structural, genetic, infectious, or lifestyle-related causes.

  2. Lifestyle changes may improve sperm quality (97%)
    • Evidence: Lifestyle changes including smoking cessation, weight loss, and increased physical activity are associated with improved sperm parameters, although high-quality data are limited.

  3. Antioxidant treatment should be about 3โ€“6 months (94%)
    • Evidence: Sperm take 2-3 months to develop, and when improvements are seen, they usually happen within 3-6 months.

  4. Sperm DNA fragmentation and oxidative stress testing may help identify underlying issues (89%)
    • Evidence: The review notes that higher sperm DNA fragmentation and oxidative stress are associated with poorer fertility outcomes, and that assessing these factors may help identify underlying causes and allow more targeted management. At the same time, the authors acknowledge that testing methods vary, randomized trials are lacking, and clinical benefit isnโ€™t clear.

  5. Antioxidants may improve outcomes for both natural and ART pregnancies, but additional randomized trials are still needed (82%)
    • Evidence: Meta-analyses suggest antioxidants may improve pregnancy or live birth rates, but evidence is low quality and based on small trials. Large randomized trials found no benefit on semen parameters, DNA integrity, or live birth, and professional guidelines note that clinical benefit remains uncertain and data are insufficient to recommend specific supplements.

  6. Antioxidants are not expected to restore sperm production in non-obstructive azoospermia patients (82%)
    • Evidence: Studies are small and inconsistent, and there is no reliable evidence that antioxidants restore sperm in the ejaculate.

GAFโ€™s weakly recommended guidelines

These guidelines were โ€œweaklyโ€ rated, meaning that <80% of experts rated the guideline as strong.

  1. Consider antioxidants for men with oxidative stress risk factors (79%)
    • Evidence: Conditions such as varicocele, infection, obesity, smoking, and advanced paternal age are linked to higher oxidative stress. Evidence that antioxidants improve fertility outcomes in these groups is limited and inconsistent, and guidelines note uncertain clinical benefit and lack of data on optimal use.

  2. Antioxidants may be considered for isolated high sperm DNA fragmentation with otherwise normal semen parameters (79%)
    • Evidence: Evidence on antioxidant therapy in male infertility is mixed, with modest improvements in sperm DNA fragmentation and semen quality but limited and uncertain clinical relevance, and no standardized treatment regimens.

  3. Antioxidants may improve semen parameters and oxidative stress markers (78%)
    • Evidence: Meta-analyses and randomized trials show that antioxidants can improve sperm concentration, motility, morphology, oxidative stress levels, and sperm DNA fragmentation, but some studies show no benefit.

  4. Combining different antioxidants is biologically plausible but unproven compared to using a single one (70%)
    • Evidence: No strong trials directly compare single antioxidants with combination products, and existing results are inconsistent.

  5. Antioxidants appear safe short term, but continuing beyond 3โ€“6 months without evidence of oxidative stress is discouraged (70%)
    • Evidence: Evidence on antioxidant duration is mixed, with small improvements seen after about 3 months and uncertain clinical benefit.

  6. Antioxidants may be considered in unexplained or idiopathic male infertility (64%)
    • Evidence: Reviews show small improvements in semen measures, but randomized trials show mixed or no effects on pregnancy or live birth.

Want to read more about supplement use and sperm quality?

If you liked this post and want to support what I do, please consider a paid subscription, Patreon or donate through PayPal!

ย 


About Embryoman

Embryoman (Sean Lauber) is a former embryologist and the founder of Remembryo, an IVF research and fertility education website. After working in an IVF lab in the US, he returned to Canada and now focuses on making fertility research more accessible. He holds a Masterโ€™s in Immunology and launched Remembryo in 2018 to help patients and professionals make sense of IVF research. Sean shares weekly study updates on Facebook, Instagram, and Reddit regularly. He also answers questions on Reddit or in his private Facebook group.


ย